Redox ticklers and beyond: Naphthoquinone repository in the spotlight against inflammation and associated maladies

Pharmacol Res. 2021 Dec:174:105968. doi: 10.1016/j.phrs.2021.105968. Epub 2021 Nov 7.

Abstract

Cellular redox status has been considered as a focal point for the pathogenesis of multiple disorders. High and persistent levels of free radicals kick off inflammation and associated disorders. Though oxidative stress at high levels is harmful but at low levels it has been shown to exert cytoprotective effects. Therefore, cytoprotection by perturbation in cellular redox balance is a leading strategy for therapeutic interventions. Prooxidants are potent redox modifiers that generate mild oxidative stress leading to a spectrum of bioactivities. Naphthoquinones are a group of highly reactive organic chemical species that interact with biological systems owing to their prooxidants nature. Owing to the ability of naphthoquinones and its derivatives to perturb redox balance in a cell and modulate redox signaling, they have been in epicenter of drug development for plausible utilization in multiple clinical settings. The present review highlights the potential of 1,4-naphthoquinone and its natural derivatives (plumbagin, juglone, lawsone, menadione, lapachol and β-lapachone) as redox modifiers with anti-inflammatory, anti-cancer, anti-diabetic and anti-microbial activities for implication in therapeutic settings.

Keywords: 1,4-naphthoquinone; Anti-cancer; Anti-diabetic; Juglone; Lawsone. anti-inflammatory; Plumbagin.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / therapeutic use*
  • Free Radicals / metabolism
  • Humans
  • Naphthoquinones / therapeutic use*
  • Oxidation-Reduction

Substances

  • Anti-Inflammatory Agents
  • Free Radicals
  • Naphthoquinones